Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy
- PMID: 22778094
- PMCID: PMC3457555
- DOI: 10.1128/IAI.00449-12
Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy
Abstract
Candida albicans is a normal member of the gastrointestinal (GI) tract microbiota of healthy humans, but during host immunosuppression or alterations in the bacterial microbiota, C. albicans can disseminate and cause life-threatening illness. The bacterial microbiome of the GI tract, including lactic acid bacteria (LAB), plays a vital role in preventing fungal invasion. However, little is known about the role of C. albicans in shaping the bacterial microbiota during antibiotic recovery. We investigated the fungal burdens in the GI tracts of germfree mice and mice with a disturbed microbiome to demonstrate the role of the microbiota in preventing C. albicans colonization. Histological analysis demonstrated that colonization with C. albicans during antibiotic treatment does not trigger overt inflammation in the murine cecum. Bacterial diversity is reduced long term following cefoperazone treatment, but the presence of C. albicans during antibiotic recovery promoted the recovery of bacterial diversity. Cefoperazone diminishes Bacteroidetes populations long term in the ceca of mice, but the presence of C. albicans during cefoperazone recovery promoted Bacteroidetes population recovery. However, the presence of C. albicans resulted in a long-term reduction in Lactobacillus spp. and promoted Enterococcus faecalis populations. Previous studies have focused on the ability of bacteria to alter C. albicans; this study addresses the ability of C. albicans to alter the bacterial microbiota during nonpathogenic colonization.
Figures
Similar articles
-
Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis.Infect Immun. 2012 Jan;80(1):150-8. doi: 10.1128/IAI.05162-11. Epub 2011 Oct 10. Infect Immun. 2012. PMID: 21986629 Free PMC article.
-
Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract.FEMS Microbiol Ecol. 2020 Jan 1;96(1):fiz187. doi: 10.1093/femsec/fiz187. FEMS Microbiol Ecol. 2020. PMID: 31769789 Free PMC article.
-
Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans.Sci Rep. 2013;3:2191. doi: 10.1038/srep02191. Sci Rep. 2013. PMID: 23846617 Free PMC article.
-
Interplay between Candida albicans and Lactic Acid Bacteria in the Gastrointestinal Tract: Impact on Colonization Resistance, Microbial Carriage, Opportunistic Infection, and Host Immunity.Clin Microbiol Rev. 2021 Dec 15;34(4):e0032320. doi: 10.1128/CMR.00323-20. Epub 2021 Jul 14. Clin Microbiol Rev. 2021. PMID: 34259567 Free PMC article. Review.
-
Metagenomics and metabolomics approaches in the study of Candida albicans colonization of host niches: a framework for finding microbiome-based antifungal strategies.Trends Microbiol. 2023 Dec;31(12):1276-1286. doi: 10.1016/j.tim.2023.08.002. Epub 2023 Aug 30. Trends Microbiol. 2023. PMID: 37652786 Review.
Cited by
-
Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study.PLoS One. 2015 Apr 24;10(4):e0124172. doi: 10.1371/journal.pone.0124172. eCollection 2015. PLoS One. 2015. PMID: 25909773 Free PMC article.
-
Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen Nakaseomyces glabratus (Candida glabrata).Front Cell Infect Microbiol. 2024 Jul 15;14:1416509. doi: 10.3389/fcimb.2024.1416509. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39077431 Free PMC article.
-
Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation.Infect Immun. 2016 Dec 29;85(1):e00807-16. doi: 10.1128/IAI.00807-16. Print 2017 Jan. Infect Immun. 2016. PMID: 27799331 Free PMC article.
-
Global hotspots and trends in gut mycological research: a visual analytics and bibliometric approach.Front Immunol. 2024 Oct 2;15:1457913. doi: 10.3389/fimmu.2024.1457913. eCollection 2024. Front Immunol. 2024. PMID: 39416793 Free PMC article.
-
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.Int J Mol Sci. 2022 Mar 23;23(7):3464. doi: 10.3390/ijms23073464. Int J Mol Sci. 2022. PMID: 35408838 Free PMC article. Review.
References
-
- Franz CM, Holzapfel WH, Stiles ME. 1999. Enterococci at the crossroads of food safety? Int. J. Food Microbiol. 47:1–24 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous